Clinical impact of Amotosalen and UV-A treatment (INTERCEPT™ Blood System) for platelet concentrate preparation in cardiac surgery.
The implementation of PRT using IBS did not impair the hemostatic properties of transfused platelets during cardiac surgery. Platelet and other blood product use, as well as clinical outcomes, were similar before and after PRT introduction. IBS-treated PCs are thus comparable to standard PCs in managing bleeding in cardiac surgery.
Authors
- Xavier Delabranche (ORCID: https://orcid.org/0000-0002-5585-6792)
- Catherine Humbrecht (ORCID: https://orcid.org/0000-0002-8963-6464)
- Gérard Audibert (ORCID: https://orcid.org/0000-0001-7919-5434)
- Paul‐Michel Mertès (ORCID: https://orcid.org/0000-0002-6060-9438)
- Charles-Ambroise Tacquard
- Walid Oulehri
- Jean-Marc Malinovsky
- Daniel Kientz
- Philippe Gomis
- François Lévy
- Olivier Collange
- A. Roche
Institutions
- Hôpital Civil, Strasbourg (FR)
- Université de Strasbourg (FR)
Publication Details
- Journal
- PubMed
- Published
- 2025-11-06
- DOI
- https://doi.org/10.2450/bloodtransfus.985
- Primary Topic
- Cardiac and Coronary Surgery Techniques
- Type
- article
- Field-Weighted Citation Impact
- 0.00